AU2001272902A1 - Treating musculoskeletal disorders using lp85 and analogs thereof - Google Patents

Treating musculoskeletal disorders using lp85 and analogs thereof

Info

Publication number
AU2001272902A1
AU2001272902A1 AU2001272902A AU7290201A AU2001272902A1 AU 2001272902 A1 AU2001272902 A1 AU 2001272902A1 AU 2001272902 A AU2001272902 A AU 2001272902A AU 7290201 A AU7290201 A AU 7290201A AU 2001272902 A1 AU2001272902 A1 AU 2001272902A1
Authority
AU
Australia
Prior art keywords
analogs
musculoskeletal disorders
treating musculoskeletal
treating
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272902A
Inventor
John Michael Beals
Patricia Ann Gonzalez-Dewhitt
Lisa Janine Hammond
Jirong Lu
Songqing Na
Eric Wen Su
Derrick Ryan Witcher
Victor John Wroblewski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2001272902A1 publication Critical patent/AU2001272902A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001272902A 2000-05-19 2001-05-08 Treating musculoskeletal disorders using lp85 and analogs thereof Abandoned AU2001272902A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US20542400P 2000-05-19 2000-05-19
US60205424 2000-05-19
US26107101P 2001-01-11 2001-01-11
US26107601P 2001-01-11 2001-01-11
US60261071 2001-01-11
US60261076 2001-01-11
PCT/US2001/011755 WO2001089450A2 (en) 2000-05-19 2001-05-08 Treating musculoskeletal disorders using lp85 and analogs thereof

Publications (1)

Publication Number Publication Date
AU2001272902A1 true AU2001272902A1 (en) 2001-12-03

Family

ID=27394788

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001272902A Abandoned AU2001272902A1 (en) 2000-05-19 2001-05-08 Treating musculoskeletal disorders using lp85 and analogs thereof

Country Status (2)

Country Link
AU (1) AU2001272902A1 (en)
WO (1) WO2001089450A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6663870B2 (en) 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US6468543B1 (en) 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
AU2002248237A1 (en) 2000-10-30 2002-08-12 Zymogenetics, Inc. Compositions and methods for improving kidney function
US7135174B2 (en) * 2002-01-07 2006-11-14 Amgen Fremont, Inc. Antibodies directed to PDGFD and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000027879A1 (en) * 1998-11-10 2000-05-18 Ludwig Institute For Cancer Research Platelet-derived growth factor d, dna coding therefor, and uses thereof
AU4714500A (en) * 1999-05-03 2000-11-17 Zymogenetics Inc. Growth factor homolog zvegf4
AU5903600A (en) * 1999-06-30 2001-01-31 Millennium Pharmaceuticals, Inc. A novel vascular endothelial growth factor family member and uses thereof
WO2001025437A2 (en) * 1999-10-07 2001-04-12 Curagen Corporation Growth factor polypeptides and nucleic acids encoding same
WO2001057083A1 (en) * 2000-02-04 2001-08-09 Zymogenetics, Inc. Methods for promoting growth of bone, ligament, and cartilage using zvegf4

Also Published As

Publication number Publication date
WO2001089450A3 (en) 2002-05-02
WO2001089450A2 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
GB0007193D0 (en) Treatment of movrmrnt disorders
GB2360534B (en) Formation treatment method using deformable particles
EP1296699A4 (en) Therapeutic agents - iii
AU2001252135A1 (en) Therapeutic agents
GB0028264D0 (en) Well treatment
GB0028269D0 (en) Well treatment
EG25829A (en) Novel treatment
AU5647601A (en) Hair treatment compositions
GB0030845D0 (en) Novel treatment
AU2001273972A1 (en) Hair treatment composition
AU2001239510A1 (en) Treatment of renal disorders
GB0009612D0 (en) Therapeutic formulations
AU2001273903A1 (en) Therapeutic agents
AU2001272902A1 (en) Treating musculoskeletal disorders using lp85 and analogs thereof
EP1291011A4 (en) Hand treatment lotion
CA91213S (en) Rollator
AU2002223679A1 (en) Hair treatment composition
AU2001287674A1 (en) Hair treatment compositions
GB0029125D0 (en) Novel treatment
AU2001263926A1 (en) Hair treatment compositions
GB2399118B (en) Formation treatment method using deformable particles
GB0019728D0 (en) Novel treatment
AU6884801A (en) Therapeutic compounds and methods
IL153788A0 (en) Treatment of eating disorders using carboxyalkylethers
GB0018373D0 (en) Cosmetic treatment